Nandani Medical Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 1.85 Cr
as on 19-12-2024
- Company Age 31 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 27.04 Cr
as on 19-12-2024
- Revenue 28.55%
(FY 2021)
- Profit 10.37%
(FY 2021)
- Ebitda -0.01%
(FY 2021)
- Net Worth 26.37%
(FY 2021)
- Total Assets 78.91%
(FY 2021)
About Nandani Medical Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.85 Cr.
The company currently has active open charges totaling ₹27.04 Cr.
Shivanshu Kharia and Shantanu Kharia serve as directors at the Company.
- CIN/LLPIN
U24232MP1993PTC007447
- Company No.
007447
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nandani Medical Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivanshu Kharia  | Director | 01-Jun-2020 | Current |
| Shantanu Kharia | Director | 01-Jun-2020 | Current |
Financial Performance of Nandani Medical Laboratories.
Nandani Medical Laboratories Pvt Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 28.55% increase. The company also saw a substantial improvement in profitability, with a 10.37% increase in profit. The company's net worth Soared by an impressive increase of 26.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nandani Medical Laboratories?
In 2021, Nandani Medical Laboratories had a promoter holding of 98.50% and a public holding of 1.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Notion Pharma Private LimitedActive 3 years 6 monthsShivanshu Kharia and Shantanu Kharia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 18 Jul 2024 | ₹1.20 Cr | Open |
Hdfc Bank Limited Creation Date: 03 Nov 2022 | ₹15.50 Cr | Open |
Sidbi Creation Date: 20 Oct 2020 | ₹1.00 Cr | Open |
How Many Employees Work at Nandani Medical Laboratories?
Nandani Medical Laboratories has a workforce of 55 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nandani Medical Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nandani Medical Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
